RxDoctor Payments DataLook up a doctor →

Jenny Lai, MD

Physical Medicine & Rehabilitation · Houston, TXNPI 1578507182

Payments from drug & device makers

$15,755in general payments, 2019–2025

Across 671 payments — averaging $23.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • Merz Pharmaceuticals, LLC$2K
  • Teva Pharmaceuticals USA, Inc.$1K
  • Ipsen Biopharmaceuticals, Inc$1K
  • Neurocrine Biosciences, Inc.$1K
  • Piramal Critical Care$745
  • plus $6K from 41 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)160$3,204
Merz Pharmaceuticals, LLC65$1,934
Teva Pharmaceuticals USA, Inc.46$1,419
Ipsen Biopharmaceuticals, Inc57$1,312
Neurocrine Biosciences, Inc.45$1,179
Piramal Critical Care39$745
Pfizer30$613
Merz North America, Inc.16$472
Amgen(2 entities)12$386
Saol Therapeutics Inc.13$371
Vertex5$305
Lilly USA, LLC14$273
MDD US Operations, LLC18$270
Biogen10$262
Biohaven Pharmaceuticals, Inc.13$260
Biohaven Pharmaceutical Holding Company Ltd.13$229
Scilex Pharmaceuticals Inc.14$226
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC14$221
Novartis9$191
Otsuka America Pharmaceutical, Inc.8$168
Collegium Pharmaceutical, Inc.10$162
Medtronic(2 entities)4$157
Lundbeck LLC5$151
GRT US Holding, Inc.7$151
Globus Medical1$147
Microtransponder, Inc.3$120
Avanir Pharmaceuticals, Inc.6$111
Revance Therapeutics, Inc.3$89
Pacira Pharmaceuticals Incorporated3$71
Redhill Biopharma Inc.4$66
AstraZeneca(2 entities)3$50
Amneal Pharmaceuticals LLC2$49
Bioventus LLC2$46
Daiichi Sankyo Inc.2$39
Averitas Pharma Inc.2$35
Acadia Pharmaceuticals Inc1$35
Axsome Therapeutics, Inc.1$33
IBSA Pharma Inc.2$32
Impel Pharmaceuticals Inc.1$28
Xeris Pharmaceuticals, Inc.1$23
Upsher-smith Laboratories LLC1$22
Kaleo, Inc.1$22
Valinor Pharma, LLC1$18
Metacel Pharmaceuticals LLC1$16
Arbor Pharmaceuticals, Inc.1$15
Dynasplint Systems Inc.1$13
Idorsia Pharmaceuticals US Inc1$13

How this compares

$15,755 in reported general payments places this provider in the 95th percentile of 651 physical medicine & rehabilitation providers in Texas.

See all physical medicine & rehabilitation providers in Texas →

Medicare billing

Part B allowed, 2024
$626,163
Medicare patients
343
Services billed
63,972

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other physical medicine & rehabilitation in Houston

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →